期刊文献+

化痰泄浊方对脂肪肝模型大鼠胰岛素抵抗及瘦素的影响 被引量:10

Effects of Huatan Xiezhuo Recipe on insulin resistance and leptin in rats with fatty liver
下载PDF
导出
摘要 目的:探讨化痰泄浊方对大鼠脂肪肝的作用。方法:将SD大鼠随机分为5组:正常对照组、模型组、东宝肝泰组、化痰泄浊方高剂量和低剂量组。用高脂饮食联合四环素腹腔注射法制作大鼠脂肪肝模型,观察大鼠肝脏组织的病理变化,并检测肝功能、血清瘦素、胰岛素抵抗指数,以及肝匀浆甘油三酯(triglyceride,TG)和游离脂肪酸(freefattyacid,FFA)的含量。结果:各用药组的血清瘦素、胰岛素抵抗指数及肝匀浆FFA、TG含量均显著低于模型组(P<0.01),且化痰泄浊方组的抗脂肪肝作用显著优于东宝肝泰组(P<0.05)。结论:化痰泄浊方治疗脂肪肝的作用机制主要为促进脂质代谢、改善胰岛素及瘦素抵抗。 Objective: To observe the effects of Huatan Xiezhuo Recipe (HTXZR) on fatty liver of rats.Methods:Forty-eight SD rats were randomly divided into five groups, normal control group, untreated group,Dongbao Gantai Tablet (DBGTT)-treated group, low-dose HTXZR-treated group and high-dose HTXZR-treated group. Fatty liver was induced in the rats by hyperlipid diet and intraperitoneal injection of tetracycline. The pathological changes of liver tissues in rats were observed, and the liver function, serum leptin, insulin resistance index, triglyceride (TG) and free fatty acid (FFA) in the liver were detected.Results: The levels of serum leptin, insulin resistance index, FFA and TG in rats of the three treated groups were lower than those of the untreated group (P〈0.01), and such effects in the HTXZR-treated groups were more significant than those in the DBGTT-treated group (P〈0.05). Conclusion:The main action mechanisms of HTXZR in treating fatty liver are probably to promote the lipid metabolism, decrease the leptin and insulin resistance.
出处 《中西医结合学报》 CAS 2005年第4期290-293,共4页 Journal of Chinese Integrative Medicine
基金 河南省科技攻关基金资助项目(No.0224630002)
关键词 化痰泄浊方 脂肪肝 游离脂肪酸 胰岛素抵抗 瘦素抵抗 Huatan Xiezhuo Recipe fatty liver free fatty acid insulin resistance leptin resistance
  • 相关文献

参考文献7

二级参考文献47

  • 1Tartaglia L. The leptin receptor [ J ]. J Biol Chem, 1997,272 (10) : 6093 -6096.
  • 2Bado A, Levasseur S, Attoub S, et al. The stomach as a source of leptin[J]. Nature, 1998,394(6695) : 790-793.
  • 3Day CP, James OF. Steatohepatitis : a tale of two “hit”[ J ] .9 Gastroenterology, 1998,114 (4) : 842-845.
  • 4Marchesini G, Bfizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance [J]. Am J Med,1999,107 (5) : 450-455.
  • 5Lin HZ , Yang SQ, Chuckaree C, et al. Metformin treatment reverses fatty liver disease in obese leptin-deficient mice [ J ]. Nature Med, 2000,6(9) :998-1003.
  • 6Cohen B, Novick D, Rubinstein M. Modulation of insulin activity by leptin [ J ]. Science, 1996,274 (5290) : 1185-1188.
  • 7Quadri R, Ruddia-Brandt L, Abid K, et al. Detection of the negativestrand hepatitis C virus RNA in tissues: implacation for pathogenesis[J] . Antiviral Res,2001,52(2) :161-171.
  • 8Koteish A, Diehl AM. Animal models of steatosis [ J ]. Sem Liv Dis,2001,21 ( 1 ) :89-104.
  • 9Uygun A, Kadayifci A, Yesilova Z, et al. Serum leptin levels in patients with nonalcoholic teatohepatitis [ J ]. Am J Gastroenterol, 2000,95 (12) :3584-3589.
  • 10Faggioni R, Jones-Carson J, Reed DA, et al. Leptin deficient (ob/ob)mice are protected from T-cell mediated hepatotoxicity: role of tumor necrosis fator alpha and IL-18[J]. Prot Natl Acad Sei USA,2000,97(5) :2367-2372.

共引文献270

同被引文献141

引证文献10

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部